https://www.planetofthevapes.co.uk/news/vaping-news/2021-01-21_farsalinos-covid-19-and-vaping.html
21 Jan. 2021
"Harm Reduction journal has published an expanded re-analysis of a recent publication by Konstantinos Farsalinos, Pantelis Bagos, Theodoros Giannouchos, Raymond Niaura, Anastasia Barbouni and Konstantinos Poulas. They examined smoking prevalence among hospitalised COVID-19 patients. Next week, Konstantinos Farsalinos will host a press conference for the launch of a Declaration on E-Cigarettes and Public Health...
The research paper says: “The same studies as examined in the previous meta-analysis were analysed. The POR [prevalence odds ratio] relative to the expected smoking prevalence was calculated using gender and age-adjusted population smoking rates. Random-effects meta-analyses were used for all other associations.”
Again, they found “a particularly low prevalence of smoking among hospitalized COVID-19”. In fact, there were 75% fewer hospitalised smokers than would normally be expected.
They concluded that smokers should still quit as soon as possible due to the health risks combusted tobacco presents but investigating the use of pharmaceutical nicotine as potential therapeutic option for COVID patients is imperative..."
21 Jan. 2021
"Harm Reduction journal has published an expanded re-analysis of a recent publication by Konstantinos Farsalinos, Pantelis Bagos, Theodoros Giannouchos, Raymond Niaura, Anastasia Barbouni and Konstantinos Poulas. They examined smoking prevalence among hospitalised COVID-19 patients. Next week, Konstantinos Farsalinos will host a press conference for the launch of a Declaration on E-Cigarettes and Public Health...
The research paper says: “The same studies as examined in the previous meta-analysis were analysed. The POR [prevalence odds ratio] relative to the expected smoking prevalence was calculated using gender and age-adjusted population smoking rates. Random-effects meta-analyses were used for all other associations.”
Again, they found “a particularly low prevalence of smoking among hospitalized COVID-19”. In fact, there were 75% fewer hospitalised smokers than would normally be expected.
They concluded that smokers should still quit as soon as possible due to the health risks combusted tobacco presents but investigating the use of pharmaceutical nicotine as potential therapeutic option for COVID patients is imperative..."
